Active surveillance and modern diagnostics of prostate cancer. Multiparametric MRI, fusion-targeted biopsy and new genetic biomarkers

被引:0
作者
Leyh-Bannurah, Sami-Ramzi [1 ,2 ]
Cash, Hannes [3 ]
Borkowetz, Angelika [4 ]
Graefen, Markus [1 ]
Schlomm, Thorsten [3 ]
Hadaschik, Boris [5 ]
Budaeus, Lars [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Prostatakarzinomzentrum, Martini Klin, Martinistr 52, D-20246 Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Klin Urol, Hamburg, Germany
[3] Charite Univ Med Berlin, Klin Urol, Berlin, Germany
[4] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin Urol, Dresden, Germany
[5] Univ Klinikum Essen, Klin Urol, Essen, Germany
来源
ONKOLOGE | 2019年 / 25卷 / 04期
关键词
PRECISION; Biparametric MRI; Evasive prostate cancer syndrome; Repeat biopsy; Active surveillance monitoring; ULTRASOUND-GUIDED BIOPSY; EXTERNAL-BEAM RADIATION; RADICAL PROSTATECTOMY; RISK STRATIFICATION; GENOMIC CLASSIFIER; COLOR DOPPLER; MEN; ACCURACY; ASSAY; ULTRASONOGRAPHY;
D O I
10.1007/s00761-019-0533-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPrimary transrectal ultrasound random biopsies do not detect all prostate cancer foci, leading to the necessity of repeat biopsies if prostate cancer suspicion persists. Moreover, corresponding false negative rates and discrepancies between biopsy Gleason scores and final radical prostatectomy pathology must be considered. These challenges potentially lead to delayed diagnosis and enable prostate cancer to gain aggressive tumor features and can be acommon reason for understaging, adverse patient outcomes or missing the window of opportunity for acure. Multiparametric magnetic resonance imaging (mpMRI) and genetic biomarkers might represent solutions to further improve prostate cancer detection and characterization in order to optimize treatment choice, such as active surveillance inclusion and monitoring.ObjectiveThis article provides an overview of active surveillance definitions, pitfalls of prostate cancer detection and characterization, implementation of mpMRI, MRI fusion targeted biopsy and genetic biomarkers as possible solutions and the integration into daily clinical practice.Material and methodsReview of the current literature and institutional experiences.ResultsThe mpMRI and MRI fusion targeted biopsy are superior to the current standard of transrectal ultrasound random biopsy in the detection of clinically significant prostate cancer. This is particularly shown in the setting of previous negative biopsy, anterior prostate cancer, persistence of suspicious PSA dynamics and active surveillance inclusion and monitoring. Similarly, the combination of other novel predictors represent promising approaches.ConclusionThe potential diagnostic value can only be achieved by an interdisciplinary combination of increasingly complex diagnostic steps. Effective solutions within the framework of interdisciplinary cooperation between radiologists and urologists at the level of the specialist societies are necessary in order to address questions regarding time expenditure and resource distribution with service providers.
引用
收藏
页码:304 / 314
页数:11
相关论文
共 52 条
[1]   Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study [J].
Ahmed, Hashim U. ;
Bosaily, Ahmed El-Shater ;
Brown, Louise C. ;
Gabe, Rhian ;
Kaplan, Richard ;
Parmar, Mahesh K. ;
Collaco-Moraes, Yolanda ;
Ward, Katie ;
Hindley, Richard G. ;
Freeman, Alex ;
Kirkham, Alex P. ;
Oldroyd, Robert ;
Parker, Chris ;
Emberton, Mark .
LANCET, 2017, 389 (10071) :815-822
[2]  
[Anonymous], 2018, INTERDISZIPLINARE LE, pS3
[3]  
[Anonymous], 2013, GLOBOCAN 2012 V1 0 C
[4]   Prostate cancers in the transition zone: Part 2; clinical aspects [J].
Augustin, H ;
Erbersdobler, A ;
Hammerer, PG ;
Graefen, M ;
Huland, H .
BJU INTERNATIONAL, 2004, 94 (09) :1226-1229
[5]   Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer [J].
Auprich, Marco ;
Bjartell, Anders ;
Chun, Felix K. -H. ;
de la Taille, Alexandre ;
Freedland, Stephen J. ;
Haese, Alexander ;
Schalken, Jack ;
Stenzl, Arnulf ;
Tombal, Bertrand ;
van der Poel, Henk .
EUROPEAN UROLOGY, 2011, 60 (05) :1045-1054
[6]   Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy [J].
Bishoff, Jay T. ;
Freedland, Stephen J. ;
Gerber, Leah ;
Tennstedt, Pierre ;
Reid, Julia ;
Welbourn, William ;
Graefen, Markus ;
Sangale, Zaina ;
Tikishvili, Eliso ;
Park, Jimmy ;
Younus, Adib ;
Gutin, Alexander ;
Lanchbury, Jerry S. ;
Sauter, Guido ;
Brawer, Michael ;
Stone, Steven ;
Schlomm, Thorsten .
JOURNAL OF UROLOGY, 2014, 192 (02) :409-414
[7]   Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy [J].
Brock, Marko ;
von Bodman, Christian ;
Sommerer, Florian ;
Loeppenberg, Bjoern ;
Klein, Tobias ;
Deix, Thomas ;
Palisaar, Jueri Rein ;
Noldus, Joachim ;
Eggert, Thilo .
BJU INTERNATIONAL, 2011, 108 (8B) :E217-E222
[8]   Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure [J].
Cash, Hannes ;
Guenzel, Karsten ;
Maxeiner, Andreas ;
Stephan, Carsten ;
Fischer, Thomas ;
Durmus, Tahir ;
Miller, Kurt ;
Asbach, Patrick ;
Haas, Matthias ;
Kempkensteffen, Carsten .
BJU INTERNATIONAL, 2016, 118 (01) :35-43
[9]   Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort [J].
Cooperberg, Matthew R. ;
Simko, Jeffry P. ;
Cowan, Janet E. ;
Reid, Julia E. ;
Djalilvand, Azita ;
Bhatnagar, Satish ;
Gutin, Alexander ;
Lanchbury, Jerry S. ;
Swanson, Gregory P. ;
Stone, Steven ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) :1428-1434
[10]   Genomic Markers in Prostate Cancer Decision Making [J].
Cucchiara, Vito ;
Cooperberg, Matthew R. ;
Dall'Era, Marc ;
Lin, Daniel W. ;
Montorsi, Francesco ;
Schalken, Jack A. ;
Evans, Christopher P. .
EUROPEAN UROLOGY, 2018, 73 (04) :572-582